Jubilant Ingrevia — 360° view

Jubilant Ingrevia, a company in the Specialty Chemicals industry, reported revenue of ₹1,394 crore and net profit of ₹111 crore for the September 2026 quarter.

Jubilant Ingrevia (NSE: JUBLINGREA) closed at ₹568.25 on 20 Nov 2026, down 21.5% over the past year. Its market capitalisation is ₹9,051 crore and it trades at 25.1 times earnings.

Share price
₹568.25 (20 Nov 2026)
Market cap
₹9,051 Cr (20 Nov 2026)
P/E
25.14 (20 Nov 2026)
Revenue
₹1,394 Cr (September 2026 quarter)
Net profit
₹111 Cr (September 2026 quarter)
ROCE
11.4% (FY26)
ROE
9.52% (FY26)
Book value
₹208 (FY26)
Dividend yield
0.88% (last 12 months to 20 Nov 2026)
52-week high / low
₹795.00 / ₹537.30 (20 Nov 2026)
1-year return
-21.5% (to 20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: JUBLINGREA

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.